Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Monetary policy could serve as a powerful tool to stimulate economic growth. It works by easing financial conditions through improved liquidity and reduced interest rates. The markets are looking for central bank leadership in the current environment of a synchronized worldwide slowdown.
The Chinese economy is slowing down, the Euro-zone seems to have slipped into a recession, and the outlook for the U.S. economy remains sub-par. The profit warning from FedEx (FDX - Analyst Report) is the latest manifestation of this worldwide phenomenon.
But the effectiveness of fresh monetary easing is unlikely to be the same in each region. Interest rates and bank reserve requirements have plenty of room to fall in China. The European Central Bank could cut short-term interest rate as well, but the more effective measure that they could do is to ease conditions for the fiscally weak nations by purchasing their bonds.
Expectations are growing that the ECB will come out with a bond-purchase program at its meeting tomorrow. Disagreements remains within the Euro-zone policy elites about the optimal course of action. But a bond purchase program could go some way towards easing pressure on the beleaguered Spanish and Italian governments.
The U.S. Fed is also expected to come out with a fresh bond-purchase program, the third for the Fed, at its meeting next week. But monetary policy may not have as much traction in the U.S. case as it is expected to have in the cases of China and the Euro-zone.
In this speech at Jackson Hole, Bernanke attributed a fair amount of economic growth to the totality of unconventional monetary measures implemented in the last three years. But with financial conditions already quite favorable, a fresh round of bond purchases may not have much relevance.
Get the full Analyst Report on FDX - FREE